FDAnews Drug Daily Bulletin

BAXTER AND JERINI ADVANCE PROGRAM TO DEVELOP NON-INTRAVENOUS HEMOPHILIA THERAPY

May 19, 2006
A A

Baxter AG and Jerini AG today announced progress in their collaborative research program to develop a non-intravenous therapy for the treatment of hemophilia. Extensive in vitro and in vivo analyses have identified several synthetic lead molecules with promising pharmacological properties.
Europa Press